Actively Recruiting
Mapping Disease Pathways for Biliary Atresia
Led by University of Pittsburgh · Updated on 2025-09-09
1100
Participants Needed
1
Research Sites
991 weeks
Total Duration
On this page
Sponsors
U
University of Pittsburgh
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project will primarily evaluate the developmental/genetic basis of biliary atresia, the most common cause of liver failure at birth, and which accounts of half of all liver transplants performed worldwide in children.
CONDITIONS
Official Title
Mapping Disease Pathways for Biliary Atresia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Living individuals diagnosed with biliary atresia
- Have received or are about to receive a liver transplant
- Receiving care at one of the participating centers: Children's Hospital of Pittsburgh, Kings College Hospital, Children's Hospital of Birmingham, or Hospital Sírio-Libanês
You will not qualify if you...
- Children in the care of the state
- Patients under temporary or informal guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15224
Actively Recruiting
Research Team
M
Morgan L Paul, BSN
CONTACT
D
Daniel Pieratt, MPA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here